BMCMI
WST icon

Bryn Mawr Capital Management Inc’s West Pharmaceutical WST Stock Holding History

Bryn Mawr Capital Management Inc’s Portfolio WST Stock Details WST Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2014
Q3 		– Sell
-17,101
Closed -$721K – 665
2014
Q2 		$721K Buy
+17,101
New +$732K 0.07% 282

Other funds holding WST

Neuberger Berman Group
Neuberger Berman Group New York $150B AUM 40.08% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
BAMCO Inc
BAMCO Inc New York $66.6B AUM 7.35% 1-Year Est. Return
KI
Kalmar Investments Greenville, Delaware $443M AUM 23.5% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
Royal Bank of Canada
Royal Bank of Canada Toronto, Ontario, Canada $672B AUM 33.48% 1-Year Est. Return

Bryn Mawr Capital Management Inc's WST Position: Q3 2014 in Review

Bryn Mawr Capital Management Inc sold out of West Pharmaceutical (WST) in Q3 2014, closing a stake of 17,101 shares — an estimated $721K sold.

Bryn Mawr Capital Management Inc first reported a position in WST in Q2 2014 and held it in 1 quarter. The position peaked at $721K in Q2 2014. 213 funds tracked by Wall St. Rank hold WST as of Q3 2014.

  • Bryn Mawr Capital Management Inc reported no remaining West Pharmaceutical position as of Q3 2014 after selling out during the quarter.
  • Bryn Mawr Capital Management Inc sold 17,101 West Pharmaceutical shares in Q3 2014, an estimated $721K.
  • Bryn Mawr Capital Management Inc first reported a position in West Pharmaceutical in Q2 2014 and held it in 1 quarter.
  • Bryn Mawr Capital Management Inc's West Pharmaceutical position peaked at $721K in Q2 2014.
  • 213 funds tracked by Wall St. Rank held West Pharmaceutical as of Q3 2014.

Based on Bryn Mawr Capital Management Inc's 13F filing for Q3 2014, filed 14 Nov 2014.